Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis.
Jindani A, Atwine D, Grint D, Bah B, Adams J, Ticona ER, Shrestha B, Agizew T, Hamid S, Jamil B, Byamukama A, Kananura K, Mugisha Taremwa I, Bonnet M, Camara LM, Bah-Sow OY, Bah KS, Bah NM, Sow M, Ticona Huaroto CE, Mugruza Pineda R, Tandukar B, Raya BB, Shrestha N, Mathoma A, Mathebula-Modongo UP, Basotli J, Irfan M, Begum D, Muzammil A, Ahmed I, Hasan R, Burgos MV, Sultan F, Hassan M, Masood I, Robb C, Decker J, Grubnic S, Butcher PD, Witney A, Dhillon J, Munshi T, Fielding K, Harrison TS. Jindani A, et al. Among authors: atwine d. NEJM Evid. 2023 Sep;2(9):EVIDoa2300054. doi: 10.1056/EVIDoa2300054. Epub 2023 Aug 22. NEJM Evid. 2023. PMID: 38320155 Clinical Trial.
A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
Jindani A, Borgulya G, de Patiño IW, Gonzales T, de Fernandes RA, Shrestha B, Atwine D, Bonnet M, Burgos M, Dubash F, Patel N, Checkley AM, Harrison TS, Mitchison D; International Consortium for Trials of Chemotherapeutic Agents in Tuberculosis, St George's University of London. Jindani A, et al. Among authors: atwine d. Int J Tuberc Lung Dis. 2016 Jun;20(6):832-8. doi: 10.5588/ijtld.15.0577. Int J Tuberc Lung Dis. 2016. PMID: 27155189 Clinical Trial.
Predictors of delayed culture conversion among Ugandan patients.
Atwine D, Orikiriza P, Taremwa I, Ayebare A, Logoose S, Mwanga-Amumpaire J, Jindani A, Bonnet M. Atwine D, et al. BMC Infect Dis. 2017 Apr 24;17(1):299. doi: 10.1186/s12879-017-2335-7. BMC Infect Dis. 2017. PMID: 28438118 Free PMC article. Clinical Trial.
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trial.
Atwine D, Baudin E, Gelé T, Muyindike W, Mworozi K, Kyohairwe R, Kananura K, Orikiriza P, Nyehangane D, K T Nanjebe D, Furlan V, Verstuyft C, Barrail-Tran A, Taburet AM, Bonnet M; ANRS 12292 Rifavirenz study group. Atwine D, et al. J Antimicrob Chemother. 2020 May 1;75(5):1250-1258. doi: 10.1093/jac/dkz557. J Antimicrob Chemother. 2020. PMID: 31999314 Clinical Trial.
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial.
Bonnet M, Vasiliu A, Tchounga BK, Cuer B, Fielding K, Ssekyanzi B, Tchakounte Youngui B, Cohn J, Dodd PJ, Tiendrebeogo G, Tchendjou P, Simo L, Okello RF, Kuate Kuate A, Turyahabwe S, Atwine D, Graham SM, Casenghi M; CONTACT study group. Bonnet M, et al. Among authors: atwine d. Lancet Glob Health. 2023 Dec;11(12):e1911-e1921. doi: 10.1016/S2214-109X(23)00430-8. Epub 2023 Oct 30. Lancet Glob Health. 2023. PMID: 37918417 Free article. Clinical Trial.
Use of colorimetric culture methods for detection of Mycobacterium tuberculosis complex isolates from sputum samples in resource-limited settings.
Boum Y 2nd, Orikiriza P, Rojas-Ponce G, Riera-Montes M, Atwine D, Nansumba M, Bazira J, Tuyakira E, De Beaudrap P, Bonnet M, Page AL. Boum Y 2nd, et al. Among authors: atwine d. J Clin Microbiol. 2013 Jul;51(7):2273-9. doi: 10.1128/JCM.00749-13. Epub 2013 May 8. J Clin Microbiol. 2013. PMID: 23658270 Free PMC article.
52 results